Literature DB >> 15471874

Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2.

Cynthia A Massaad1, Bryce P Portier, Giulio Taglialatela.   

Abstract

Using a reporter gene assay in PC12, HEK293, HeLa, and NIH-3T3 cells, we show that the anti-apoptotic protein Bcl-2 significantly inhibits transcriptional activation of various transcription factors, including NF kappa B, AP1, CRE, and NFAT. A Bcl-2 mutant lacking its BH4 domain (Delta BH4) also inhibited transcription, whereas a Bcl-2 mutant lacking its transmembrane domain (Delta TM) was ineffective. Furthermore, Bcl-2 chimeric proteins containing transmembrane domains from the mitochondrial protein monoamine oxidase B (MaoB) or the endoplasmic reticulum protein cytochrome b(5) showed no effect on transcription factor activity. Subcellular localization studies showed that under conditions of transient transfection, the active Bcl-2 forms (wild type and Delta BH4) were predominantly found in the nuclear fraction, whereas the non-active forms (Delta TM, MaoB, and cytochrome b(5)) were in the non-nuclear fraction. Additionally, stably expressed Bcl-2 loses its ability to inhibit transcriptional activation and localizes predominantly to the non-nuclear fraction. Expression of FKBP38 (a chaperone that shuttles Bcl-2 to the mitochondria) removes co-expressed Bcl-2 from the nuclear fraction and reverses its effect on transcription factor activity. Finally, using an inducible gene expression system, we show that nuclear compartment-associated Bcl-2 prevents entry of NF kappa B subunits to the nucleus without affecting NF kappa B release from its cytosolic inhibitory sub-unit I kappa B alpha. These results suggest that (a) Bcl-2 suppresses transcriptional activity of multiple transcription factors; (b) Bcl-2 does not interfere with NF kappa B activation but prevents entrance of its active subunits to the nucleus; (c) membrane anchoring is required for this function of Bcl-2; and (d) association of Bcl-2 with the nuclear compartment is also necessary. We speculate that nuclear compartment-associated Bcl-2 may affect nuclear trafficking of multiple factors necessary for transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471874     DOI: 10.1074/jbc.M407659200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Cell death in mammalian cell culture: molecular mechanisms and cell line engineering strategies.

Authors:  Britta Krampe; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2010-05-26       Impact factor: 2.058

2.  BCL2L12A localizes to the cell nucleus and induces growth inhibition through G2/M arrest in CHO cells.

Authors:  Yi Hong; Junwu Yang; Yayun Chi; Wenzong Wang; Weibing Wu; Xiaojing Yun; Xiangfei Kong; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2010-01       Impact factor: 3.396

3.  Bcl-2 regulator FKBP38 is activated by Ca2+/calmodulin.

Authors:  Frank Edlich; Matthias Weiwad; Frank Erdmann; Jörg Fanghänel; Franziska Jarczowski; Jens-Ulrich Rahfeld; Gunter Fischer
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

Review 4.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

5.  Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture.

Authors:  A M Bielecka; M Paul-Samojedny; E Obuchowicz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-09-02       Impact factor: 3.000

6.  Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis.

Authors:  Melisa A Martínez-Paniagua; Stavroula Baritaki; Sara Huerta-Yepez; Vianney F Ortiz-Navarrete; Cesar González-Bonilla; Benjamin Bonavida; Mario I Vega
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

7.  Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation.

Authors:  Christina Batsi; Soultana Markopoulou; Evangelos Kontargiris; Christiana Charalambous; Christoforos Thomas; Savvas Christoforidis; Panagiotis Kanavaros; Andreas I Constantinou; Kenneth B Marcu; Evangelos Kolettas
Journal:  Biochem Pharmacol       Date:  2009-03-27       Impact factor: 5.858

8.  Bim nuclear translocation and inactivation by viral interferon regulatory factor.

Authors:  Young Bong Choi; John Nicholas
Journal:  PLoS Pathog       Date:  2010-08-05       Impact factor: 6.823

9.  Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90.

Authors:  Daniela Trisciuoglio; Chiara Gabellini; Marianna Desideri; Elio Ziparo; Gabriella Zupi; Donatella Del Bufalo
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

10.  BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional repressor of apoptosis-inducing factor expression preventing cell death in human malignant gliomas.

Authors:  Teralee R Burton; David D Eisenstat; Spencer B Gibson
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.